NCT05206578View on ClinicalTrials.gov

Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

PHASE3UnknownINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

December 8, 2020

Primary Completion Date

July 7, 2022

Study Completion Date

September 8, 2022

Conditions
Primary Hypercholesterolemia
Interventions
DRUG

AGT2, AGZ

Tablet, q.d.

DRUG

AGT2

Tablet, q.d.

DRUG

AGT4, AGZ

Tablet, q.d.

DRUG

AGT4

Tablet, q.d.

Trial Locations (1)

Unknown

RECRUITING

Yonsei severance Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Ahn-Gook Pharmaceuticals Co.,Ltd

INDUSTRY

NCT05206578 - Study to Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia | Biotech Hunter | Biotech Hunter